IP Library Granted Patent US 10,004,836
Granted Patent B2
US 10,004,836 · App. 14/496,362 · Granted Jun 26, 2018

Power assisted lipoplasty

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,836
App. No.
14/496,362
Granted
Jun 26, 2018
Kind
B2
Abstract

Devices with a motor that, when connected to a cannula, rotates the cannula while removing adipose tissue from a surgical site. The device provides a direct pathway, for aspirated adipose tissue, from a tip of the cannula to a location where tubing is attached to the device. The pathway does not pass through the motor that provides the angular rotation of the cannula. Instead, the path for the adipose tissue passes through a removable coupler that is connected to the cannula. The cannula may also have a direct flow path for adipose tissue that does not pass through the motor.

Claims (39)

1. A device for use in removing adipose tissue from a surgical site, the device comprising:

a removable coupler configured to be connected to a cannula so that a channel of the cannula and a channel of the removable coupler provide a pathway for flow of adipose tissue from a surgical site, the removable coupler including a distal end, a cavity located in the distal end and having interior walls, and a plurality of venting channels on the interior walls of the cavity and through which the cannula is vented to permit continual flow of the adipose tissue if the pathway is blocked upstream of the venting channels;

a motor connected to the removable coupler; and

a housing that surrounds at least a portion of the motor and at least a portion of the removable coupler,

wherein a central axis of the motor is adjacent a central axis of the removable coupler so that the pathway does not pass through the motor.

2. The device of claim 1 wherein, when the removable coupler is connected to a cannula, the channel of the cannula and the channel of the removable coupler are substantially collinear.

3. The device of claim 1 further comprising:

a gear connected to the motor,

wherein the motor rotates the gear at least 90°.

4. The device of claim 3 wherein the motor rotates the gear clockwise and counterclockwise.

5. The device of claim 1 wherein the channel of the removable coupler is tapered.

6. The device of claim 1 wherein the housing comprises a channel, and the removable coupler is positioned within the channel of the housing.

7. The device of claim 1 wherein the removable coupler has a surface that contacts a portion of the motor to prevent rotation of the removable coupler.

8. The device of claim 1 wherein the removable coupler includes a plurality of features, and the housing includes a plurality of features configured to engage the features of the removable coupler for connecting the motor to the removable coupler.

9. A device for use in fragmenting and removing adipose tissue from a surgical site, the device comprising:

a removable coupler configured to be connected to a cannula so that a channel of the cannula and a channel of the removable coupler provide a pathway for flow of adipose tissue from a surgical site, the removable coupler including a distal end, a cavity located in the distal end and having interior walls, and a plurality of venting channels on the interior walls of the cavity and through which the cannula is vented to permit continual flow of the adipose tissue if the pathway is blocked upstream of the venting channels;

a motor connected to the removable coupler, wherein a central axis of the motor is adjacent a central axis of the removable coupler so that the pathway does not pass through the motor;

a housing that surrounds at least a portion of the motor and at least a portion of the removable coupler;

a first gear connected to the motor, wherein the motor is configured to rotate the first gear in at least one direction; and

a second gear configured to be connected to the cannula,

wherein the second gear transfers the rotation of the first gear into rotation of the cannula.

10. The device of claim 9 wherein when the removable coupler is connected to a cannula, and the channel of the cannula and the channel of the removable coupler are substantially collinear.

11. The device of claim 9 wherein the motor rotates the first gear at least 90°.

12. The device of claim 9 wherein the motor rotates the first gear clockwise and counterclockwise.

13. The device of claim 9 wherein the removable coupler has a surface that contacts a portion of the motor to prevent rotation of the removable coupler.

14. The device of claim 9 wherein the removable coupler includes a plurality of features, and the housing includes a plurality of features configured to engage the features of the removable coupler for connecting the motor to the removable coupler.

15. A device for fragmenting and removing adipose tissue from a surgical site, the device comprising:

a cannula including a channel;

a removable coupler connected to the cannula so that the channel of the cannula and a channel of the removable coupler provide a pathway for flow of adipose tissue from a surgical site, the removable coupler including a distal end, a cavity located in the distal end and having interior walls, and a plurality of venting channels on the interior walls of the cavity and through which the cannula is vented to permit continual flow of the adipose tissue if the pathway is blocked upstream of the venting channels;

a motor connected to the removable coupler, wherein a central axis of the motor is adjacent a central axis of the removable coupler so that the pathway does not pass through the motor;

a housing that surrounds at least a portion of the motor and at least a portion of the removable coupler;

a first gear connected to the motor, wherein the motor is configured to rotate the first gear in at least one direction; and

a second gear connected to the cannula and mechanically connected to the first gear,

wherein the second gear transfers the rotation of the first gear into rotation of the cannula.

16. The device of claim 15 wherein the channel of the cannula and the channel of the removable coupler are substantially collinear.

17. The device of claim 15 wherein the motor rotates the cannula at least 90 degrees in one direction.

18. The device of claim 15 wherein the second gear is engaged with the first gear.

19. The device of claim 15 wherein the removable coupler has a surface that contacts a portion of the motor to prevent rotation of the removable coupler.

20. The device of claim 15 wherein the removable coupler includes a plurality of features, and the housing includes a plurality of features configured to engage the features of the removable coupler for connecting the motor to the removable coupler.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
MERGER Recorded Sep 15, 2020
From: SOUND SURGICAL TECHNOLOGIES LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 053773/0913 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →